TPSF
ITOS

Texas Permanent School Fund’s iTeos Therapeutics ITOS Stock Holding History

Texas Permanent School Fund’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,109
Closed -$242K – 1521
2023
Q3 		$242K Buy
22,109
+670
+3% +$8.57K ﹤0.01% 1508
2023
Q2 		$284K Sell
21,439
-295
-1% -$4.21K ﹤0.01% 1504
2023
Q1 		$296K Buy
21,734
+5,232
+32% +$93.7K ﹤0.01% 1492
2022
Q4 		$322K Sell
16,502
-1,155
-7% -$22.6K ﹤0.01% 1441
2022
Q3 		$336K Buy
17,657
+3,015
+21% +$69.5K 0.01% 1428
2022
Q2 		$302K Buy
14,642
+388
+3% +$9.21K ﹤0.01% 1452
2022
Q1 		$459K Buy
+14,254
New +$518K 0.01% 1406

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Texas Permanent School Fund's ITOS Position: Q4 2023 in Review

Texas Permanent School Fund sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 22,109 shares — an estimated $242K sold.

Texas Permanent School Fund first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $459K in Q1 2022. 137 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Texas Permanent School Fund reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Texas Permanent School Fund sold 22,109 iTeos Therapeutics shares in Q4 2023, an estimated $242K.
  • Texas Permanent School Fund first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • Texas Permanent School Fund's iTeos Therapeutics position peaked at $459K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Texas Permanent School Fund's 13F filing for Q4 2023, filed 8 Feb 2024.